Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. (4th November 2015) - Sznol, Mario; Fishman, Mayer; Escudier, Bernard; McDermott, David F; Kluger, Harriet; Stadler, Walter M; Perez-Gracia, Jose; McNeel, Douglas G; Curti, Brendan D; Harrison, Michael R; Plimack, Elizabeth R; Appleman, Leonard; et al.